Treatment-Emergent Mutations and Resistance in HIV-Infected Children Treated with Fosamprenavir-Containing Antiretroviral Regimens

Treatment-emergent mutations and drug resistance were analyzed in virus from HIV-infected children meeting virologic failure (VF) criteria over 48 weeks following treatment with unboosted fosamprenavir or fosamprenavir/ritonavir-containing regimens in studies APV20002 and APV29005. Both antiretrovir...

Descripción completa

Detalles Bibliográficos
Autores principales: Ross, Lisa L, Cotton, Mark F, Cassim, Haseena, Voronin, Eugeny, Givens, Naomi, Sievers, Jorg, Cheng, Katharine Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484231/
https://www.ncbi.nlm.nih.gov/pubmed/26157536
http://dx.doi.org/10.2174/1874613601509010038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484231/
https://www.ncbi.nlm.nih.gov/pubmed/26157536
http://dx.doi.org/10.2174/1874613601509010038

Ejemplares similares